111 related articles for article (PubMed ID: 27359042)
1. IDD388 Polyhalogenated Derivatives as Probes for an Improved Structure-Based Selectivity of AKR1B10 Inhibitors.
Cousido-Siah A; Ruiz FX; Fanfrlík J; Giménez-Dejoz J; Mitschler A; Kamlar M; Veselý J; Ajani H; Parés X; Farrés J; Hobza P; Podjarny AD
ACS Chem Biol; 2016 Oct; 11(10):2693-2705. PubMed ID: 27359042
[TBL] [Abstract][Full Text] [Related]
2. X-ray structure of the V301L aldo-keto reductase 1B10 complexed with NADP(+) and the potent aldose reductase inhibitor fidarestat: implications for inhibitor binding and selectivity.
Ruiz FX; Cousido-Siah A; Mitschler A; Farrés J; Parés X; Podjarny A
Chem Biol Interact; 2013 Feb; 202(1-3):178-85. PubMed ID: 23295227
[TBL] [Abstract][Full Text] [Related]
3. Structural basis for the inhibition of AKR1B10 by the C3 brominated TTNPB derivative UVI2008.
Ruiz FX; Crespo I; Álvarez S; Porté S; Giménez-Dejoz J; Cousido-Siah A; Mitschler A; de Lera ÁR; Parés X; Podjarny A; Farrés J
Chem Biol Interact; 2017 Oct; 276():174-181. PubMed ID: 28161411
[TBL] [Abstract][Full Text] [Related]
4. Inhibitor selectivity between aldo-keto reductase superfamily members AKR1B10 and AKR1B1: role of Trp112 (Trp111).
Zhang L; Zhang H; Zhao Y; Li Z; Chen S; Zhai J; Chen Y; Xie W; Wang Z; Li Q; Zheng X; Hu X
FEBS Lett; 2013 Nov; 587(22):3681-6. PubMed ID: 24100137
[TBL] [Abstract][Full Text] [Related]
5. Structural Determinants of the Selectivity of 3-Benzyluracil-1-acetic Acids toward Human Enzymes Aldose Reductase and AKR1B10.
Ruiz FX; Cousido-Siah A; Porté S; Domínguez M; Crespo I; Rechlin C; Mitschler A; de Lera ÁR; Martín MJ; de la Fuente JÁ; Klebe G; Parés X; Farrés J; Podjarny A
ChemMedChem; 2015 Dec; 10(12):1989-2003. PubMed ID: 26549844
[TBL] [Abstract][Full Text] [Related]
6. Identification of a novel polyfluorinated compound as a lead to inhibit the human enzymes aldose reductase and AKR1B10: structure determination of both ternary complexes and implications for drug design.
Cousido-Siah A; Ruiz FX; Mitschler A; Porté S; de Lera ÁR; Martín MJ; Manzanaro S; de la Fuente JA; Terwesten F; Betz M; Klebe G; Farrés J; Parés X; Podjarny A
Acta Crystallogr D Biol Crystallogr; 2014 Mar; 70(Pt 3):889-903. PubMed ID: 24598757
[TBL] [Abstract][Full Text] [Related]
7. Perspective on the Structural Basis for Human Aldo-Keto Reductase 1B10 Inhibition.
Ruiz FX; Parés X; Farrés J
Metabolites; 2021 Dec; 11(12):. PubMed ID: 34940623
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and structure-activity relationship of 2-phenyliminochromene derivatives as inhibitors for aldo-keto reductase (AKR) 1B10.
Endo S; Hu D; Suyama M; Matsunaga T; Sugimoto K; Matsuya Y; El-Kabbani O; Kuwata K; Hara A; Kitade Y; Toyooka N
Bioorg Med Chem; 2013 Nov; 21(21):6378-84. PubMed ID: 24071447
[TBL] [Abstract][Full Text] [Related]
9. Modulation of aldose reductase inhibition by halogen bond tuning.
Fanfrlík J; Kolář M; Kamlar M; Hurný D; Ruiz FX; Cousido-Siah A; Mitschler A; Rezáč J; Munusamy E; Lepšík M; Matějíček P; Veselý J; Podjarny A; Hobza P
ACS Chem Biol; 2013 Nov; 8(11):2484-92. PubMed ID: 23988122
[TBL] [Abstract][Full Text] [Related]
10. Structural analysis of sulindac as an inhibitor of aldose reductase and AKR1B10.
Cousido-Siah A; Ruiz FX; Crespo I; Porté S; Mitschler A; Parés X; Podjarny A; Farrés J
Chem Biol Interact; 2015 Jun; 234():290-6. PubMed ID: 25532697
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and biological evaluation of steroidal derivatives as selective inhibitors of AKR1B10.
Zhang W; Wang L; Zhang L; Chen W; Chen X; Xie M; Yan G; Hu X; Xu J; Zhang J
Steroids; 2014 Aug; 86():39-44. PubMed ID: 24793566
[TBL] [Abstract][Full Text] [Related]
12. Inhibitory selectivity to the AKR1B10 and aldose reductase (AR): insight from molecular dynamics simulations and free energy calculations.
Lin P; Niu Y
RSC Adv; 2023 Sep; 13(38):26709-26718. PubMed ID: 37681045
[TBL] [Abstract][Full Text] [Related]
13. Selective inhibition of the tumor marker aldo-keto reductase family member 1B10 by oleanolic acid.
Takemura M; Endo S; Matsunaga T; Soda M; Zhao HT; El-Kabbani O; Tajima K; Iinuma M; Hara A
J Nat Prod; 2011 May; 74(5):1201-6. PubMed ID: 21561086
[TBL] [Abstract][Full Text] [Related]
14. Design and synthesis of polyhydroxy steroids as selective inhibitors against AKR1B10 and molecular docking.
Chen W; Chen X; Zhou S; Zhang H; Wang L; Xu J; Hu X; Yin W; Yan G; Zhang J
Steroids; 2016 Jun; 110():1-8. PubMed ID: 26968129
[TBL] [Abstract][Full Text] [Related]
15. Selective inhibition of the tumor marker AKR1B10 by antiinflammatory N-phenylanthranilic acids and glycyrrhetic acid.
Endo S; Matsunaga T; Soda M; Tajima K; Zhao HT; El-Kabbani O; Hara A
Biol Pharm Bull; 2010; 33(5):886-90. PubMed ID: 20460771
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis and evaluation of caffeic acid phenethyl ester-based inhibitors targeting a selectivity pocket in the active site of human aldo-keto reductase 1B10.
Soda M; Hu D; Endo S; Takemura M; Li J; Wada R; Ifuku S; Zhao HT; El-Kabbani O; Ohta S; Yamamura K; Toyooka N; Hara A; Matsunaga T
Eur J Med Chem; 2012 Feb; 48():321-9. PubMed ID: 22236472
[TBL] [Abstract][Full Text] [Related]
17. Structural basis for the inhibition of AKR1B10 by caffeic acid phenethyl ester (CAPE).
Zhang L; Zhang H; Zheng X; Zhao Y; Chen S; Chen Y; Zhang R; Li Q; Hu X
ChemMedChem; 2014 Apr; 9(4):706-9. PubMed ID: 24436249
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis, structure-activity relationships and X-ray structural studies of novel 1-oxopyrimido[4,5-c]quinoline-2-acetic acid derivatives as selective and potent inhibitors of human aldose reductase.
Crespo I; Giménez-Dejoz J; Porté S; Cousido-Siah A; Mitschler A; Podjarny A; Pratsinis H; Kletsas D; Parés X; Ruiz FX; Metwally K; Farrés J
Eur J Med Chem; 2018 May; 152():160-174. PubMed ID: 29705708
[TBL] [Abstract][Full Text] [Related]
19. Potent and selective inhibition of the tumor marker AKR1B10 by bisdemethoxycurcumin: probing the active site of the enzyme with molecular modeling and site-directed mutagenesis.
Matsunaga T; Endo S; Soda M; Zhao HT; El-Kabbani O; Tajima K; Hara A
Biochem Biophys Res Commun; 2009 Nov; 389(1):128-32. PubMed ID: 19706287
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of aldo-keto reductase family 1 member B10 by unsaturated fatty acids.
Hara A; Endo S; Matsunaga T; Soda M; El-Kabbani O; Yashiro K
Arch Biochem Biophys; 2016 Nov; 609():69-76. PubMed ID: 27665999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]